13F filer · CIK 1513038 ↗
Perkins Coie Trust Co
You are looking at Q4 2023. See the latest, Q3 2026 →
Reported value
$396.1M
+12% on the quarter before
Positions
317
4 new · 317 sold out
Top 10
41.8%
of the value
Est. gain
+$40.3M
on stocks held all quarter
Est. return
+11.8%
on those stocks since Q3 2023
Positions as of Dec 31, 2023, from Perkins Coie Trust Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 63% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2023. Striped tiles are options.
Largest buys
Since Q3 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Vanguard Ftse Developed Mkts Index ETF Shs~$2.5MAdded · 7.2% → 7.7%+51,815 shares
- Eli Lilly~$2.0MAdded · 0.1% → 0.6%+3,390 shares
- Ishares Russell 2000 ETF~$1.7MAdded · 0.7% → 1.1%+8,357 shares
- Boeing Co~$1.2MAdded · 2.3% → 3.1%+4,488 shares
- Ishares Us Technology ETF~$1.2MAdded · 0.8% → 1.2%+9,420 shares
- D R Horton Incorporated~$1.1MAdded · 0.2% → 0.6%+7,239 shares
- Amazon~$826,236Added · 1.1% → 1.3%+5,438 shares
- Veralto Corp Usd 0.01~$558,618New · 0.0% → 0.1%+6,792 shares
- Vanguard Mid Cap ETF~$472,489Added · 7.0% → 7.1%+2,031 shares
- Ishares Nasdaq Biotech Indx~$412,023Added · 0.7% → 0.8%+3,033 shares
Largest sells
Since Q3 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Pnc Financial Services Group~$2.7MCut · 0.8% → 0.2%−17,441 shares
- Rtx Corporation~$1.6MCut · 0.5% → 0.1%−19,293 shares
- Air Products & Chemicals Inc~$1.2MCut · 0.8% → 0.4%−4,438 shares
- Ishares S&P 500 Growth ETF~$903,150Cut · 3.0% → 2.7%−12,026 shares
- Cvs Health Corp~$853,613Cut · 1.0% → 0.8%−10,811 shares
- Apple~$633,228Cut · 5.0% → 4.9%−3,289 shares
- Microsoft~$390,694Cut · 6.0% → 6.3%−1,039 shares
- Ishares California Muni Bond ETF~$384,921Sold out · 0.1% → 0.0%−7,019 shares
- SPDR S&P Biotech ETF~$338,226Cut · 0.2% → 0.2%−3,788 shares
- Target Corp~$297,221Cut · 0.7% → 0.7%−2,087 shares
Holdings
As of Dec 31, 2023. Changes are in shares against Sep 30, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanguard Ftse Developed Mkts Index ETF ShsEQUITY - INTERNATIONAL - ETF · shares +8.9% · price +9.6% | 7.7% | $30.4M | +$2.4M | ||||||||
| Vanguard Mid Cap ETFEQUITY - MIDCAP - ETF · shares +1.7% · price +11.7% | 7.1% | $28.0M | +$2.9M | ||||||||
| MicrosoftCOMMON STOCK · shares −1.5% · price +19.1% | 6.3% | $25.1M | +$4.0M | ||||||||
| AppleCOMMON STOCK · shares −3.2% · price +12.5% | 4.9% | $19.3M | +$2.1M | ||||||||
| Vanguard Russell 1000 Growth ETFEQUITY - LARGE CAP - ETF · shares −0.6% · price +14.0% | 3.5% | $14.0M | +$1.7M | ||||||||
| Boeing CoCOMMON STOCK · shares +11% · price +36.0% | 3.1% | $12.2M | +$2.9M | ||||||||
| Ishares S&P 500 Growth ETFEQUITY - LARGE CAP - ETF · shares −7.7% · price +9.8% | 2.7% | $10.9M | +$967,587 | ||||||||
| AlphabetCOMMON STOCK · shares +0.5% · price +6.7% | 2.3% | $9.3M | +$583,494 | ||||||||
| Vanguard Mid Cap ETFEQUITY - MIDCAP - ETF · shares 0% · price +11.7% | 2.1% | $8.3M | +$874,618 | ||||||||
| Visa Inc.COMMON STOCK · shares −1.4% · price +13.2% | 2.1% | $8.2M | +$957,638 | ||||||||
| QualcommCOMMON STOCK · shares −1.1% · price +30.2% | 1.9% | $7.6M | +$1.8M | ||||||||
| Home Depot IncCOMMON STOCK · shares −0.7% · price +14.7% | 1.9% | $7.6M | +$972,575 | ||||||||
| Eaton Corp PlcFOREIGN EQUITIES · shares −1.3% · price +12.9% | 1.7% | $6.9M | +$784,199 | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares −4.3% · price +4.4% | 1.6% | $6.4M | +$272,076 | ||||||||
| OracleCOMMON STOCK · shares −2.1% · price −0.5% | 1.6% | $6.2M | −$28,756 | ||||||||
| Procter & Gamble CoCOMMON STOCK · shares −1.6% · price +0.5% | 1.5% | $5.8M | +$26,887 | ||||||||
| Chevron CorpCOMMON STOCK · shares +2.8% · price −11.5% | 1.4% | $5.7M | −$724,841 | ||||||||
| IntelCOMMON STOCK · shares +2.1% · price +41.4% | 1.4% | $5.7M | +$1.6M | ||||||||
| Pepsico IncCOMMON STOCK · shares −1.9% · price +0.2% | 1.4% | $5.6M | +$13,131 | ||||||||
| CiscoCOMMON STOCK · shares −1.1% · price −6.0% | 1.4% | $5.5M | −$352,618 | ||||||||
| BlackRockCOMMON STOCK · shares −4.2% · price +25.6% | 1.4% | $5.5M | +$1.1M | ||||||||
| AmazonCOMMON STOCK · shares +18% · price +19.5% | 1.3% | $5.3M | +$733,155 | ||||||||
| Starbucks CorpCOMMON STOCK · shares +1.5% · price +5.2% | 1.3% | $5.3M | +$258,154 | ||||||||
| Accenture PlcCOMMON STOCK · shares −2.4% · price +14.3% | 1.3% | $5.2M | +$650,695 | ||||||||
| Charles Schwab CorpCOMMON STOCK · shares +1.0% · price +25.3% | 1.2% | $4.9M | +$969,436 | ||||||||
| Total · 317 positions | 100% | $396.1M | +$40.3M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2023 to Q4 2023: 312 stocks held throughout, up $40.3M (+11.8%).
- Microsoft+$4.0M+19%
- Boeing Co+$2.9M+36%
- Vanguard Mid Cap ETF+$2.9M+12%
- Vanguard Ftse Developed Mkts Index ETF Shs+$2.4M+10%
- Apple+$2.1M+12%
- Exxon Mobil Corp−$137,929−15%
- Danaher Corp−$347,490−7%
- Cisco−$352,618−6%
- Pfizer Inc−$433,999−13%
- Chevron Corp−$724,841−12%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 14, 2026 | $625.7M+4% | SEC ↗ |
| Q2 2026 | Jul 9, 2026 | $603.3M+16% | SEC ↗ |
| Q1 2026 | Apr 15, 2026 | $520.1M−3% | SEC ↗ |
| Q4 2025 | Jan 12, 2026 | $537.0M+1% | SEC ↗ |
| Q3 2025 | Oct 9, 2025 | $531.5M−9% | SEC ↗ |
| Q2 2025 | Jul 10, 2025 | $587.1M+33% | SEC ↗ |
| Q1 2025 | Apr 11, 2025 | $441.0M−3% | SEC ↗ |
| Q4 2024 | Jan 16, 2025 | $454.4M+1% | SEC ↗ |
| Q3 2024 | Oct 8, 2024 | $450.9M+5% | SEC ↗ |
| Q2 2024 | Jul 15, 2024 | $430.1M+1% | SEC ↗ |
| Q1 2024 | Apr 12, 2024 | $426.7M+8% | SEC ↗ |
| Q4 2023 | Jan 9, 2024 | $396.1M+12% | SEC ↗ |
| Q3 2023 | Oct 11, 2023 | $354.4M+1% | SEC ↗ |
| Q2 2023 | Jul 14, 2023 | $352.1M+5% | SEC ↗ |
| Q1 2023 | Apr 13, 2023 | $333.8M+7% | SEC ↗ |
| Q4 2022 | Jan 18, 2023 | $312.8M+20% | SEC ↗ |
| Q3 2022 | Oct 7, 2022 | $260.9M−5% | SEC ↗ |
| Q2 2022 | Jul 8, 2022 | $274.7M−15% | SEC ↗ |
| Q1 2022 | Apr 15, 2022 | $322.1M−6% | SEC ↗ |
| Q4 2021 | Jan 13, 2022 | $341.1M+7% | SEC ↗ |
| Q3 2021 | Oct 13, 2021 | $319.7M−2% | SEC ↗ |
| Q2 2021 | Jul 14, 2021 | $324.9M+8% | SEC ↗ |
| Q1 2021 | Apr 13, 2021 | $300.0M+2% | SEC ↗ |
| Q4 2020 | Jan 12, 2021 | $293.0M+17% | SEC ↗ |
| Q3 2020 | Oct 13, 2020 | $250.5M+3% | SEC ↗ |
| Q2 2020 | Jul 13, 2020 | $243.1M+24% | SEC ↗ |
| Q1 2020 | Apr 10, 2020 | $196.4M−20% | SEC ↗ |
| Q4 2019 | Jan 9, 2020 | $244.1M+8% | SEC ↗ |
| Q3 2019 | Oct 11, 2019 | $225.8M+3% | SEC ↗ |
| Q2 2019 | Jul 10, 2019 | $220.1M+2% | SEC ↗ |
| Q1 2019 | Apr 8, 2019 | $215.0M+13% | SEC ↗ |
| Q4 2018 | Jan 15, 2019 | $191.0M−11% | SEC ↗ |
| Q3 2018 | Oct 15, 2018 | $215.4M+6% | SEC ↗ |
| Q2 2018 | Jul 17, 2018 | $202.3M+0% | SEC ↗ |
| Q1 2018 | Apr 16, 2018 | $201.4M+1% | SEC ↗ |
| Q4 2017 | Jan 12, 2018 | $200.2M+4% | SEC ↗ |
| Q3 2017 | Oct 13, 2017 | $192.6M+4% | SEC ↗ |
| Q2 2017 | Jul 10, 2017 | $185.8M+9% | SEC ↗ |
| Q1 2017 | Apr 11, 2017 | $170.1M+3% | SEC ↗ |
| Q4 2016 | Jan 10, 2017 | $164.8M+5% | SEC ↗ |
| Q3 2016 | Oct 11, 2016 | $157.7M+4% | SEC ↗ |
| Q2 2016 | Jul 8, 2016 | $151.6M+3% | SEC ↗ |
| Q1 2016 | Apr 15, 2016 | $147.0M | SEC ↗ |